Marschall S Runge MD PhD
Adult Congenital Heart Disease
Cardiologist - Author of The Great Healthcare Disruption - Former CEO, Michigan Medicine
Join to view full profile
1500 E Medical Center DrAnn Arbor, MI 48109
Phone+1 734-936-4000
Dr. Runge is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Marschall S. Runge, MD, PhD, is a cardiologist and molecular biologist who served as Executive Vice President for Medical Affairs at the University of Michigan, Dean of the U-M Medical School, and CEO of Michigan Medicine. He trained at Vanderbilt University, Johns Hopkins, and Massachusetts General Hospital. His research spans oxidative stress, mitochondrial dysfunction, and the cellular drivers of cardiovascular and epigenetic aging. He is the author of The Great Healthcare Disruption (Forbes Books, 2025), a Global Book Awards Gold Medal winner, and the novel Coded to Kill (2023).
Education & Training
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1986 - 1989
Johns Hopkins UniversityInternship, Internal Medicine, 1984 - 1985- Johns Hopkins University School of MedicineClass of 1984
Certifications & Licensure
MI State Medical License 2015 - 2028
NC State Medical License 2000 - 2027
TX State Medical License 1994 - 2027
GA State Medical License 1989 - 1997
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1999
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- Corrigendum to 'NADPH oxidase 4 regulates vascular inflammation in aging and atherosclerosis' [Journal of Molecular and Cellular Cardiology 102 (2017) 10-21].Andrey Lozhkin, Aleksandr E Vendrov, Hua Pan, Samuel A Wickline, Nageswara R Madamanchi
Journal of Molecular and Cellular Cardiology. 2026-05-01 - Corrigendum to: "NOXA1-dependent NADPH oxidase regulates redox signaling and phenotype of vascular smooth muscle cell during atherogenesis" [Red. Biol. 71 (2019) 101063].Aleksandr E Vendrov, Arihiro Sumida, Chandrika Canugovi, Andrey Lozhkin, Takayuki Hayami
Redox Biology. 2026-03-01 - Correction: Oxidative Stress, NADPH Oxidases, and Arteries.Qi-An Sun, Marschall S Runge, Nageswara R Madanchi
Hamostaseologie. 2026-02-01
Books/Book Chapters
Press Mentions
The Blood Pressure-Lowering Fruit That No One’s Talking About, According to CardiologistsNovember 18th, 2025- AI May Diagnose an Illness—but Only Trust Can Heal HealthcareSeptember 11th, 2025
- 5 Game-Changing Books Shaping the Future of MedicineJuly 21st, 2025
Grant Support
- CTSA Infrastructure For Pediatric ResearchNational Center For Research Resources2011
- CTSA Infrastructure For Clinical TrialsNational Center For Research Resources2011
- CTSA Infrastructure For AIDS ResearchNational Center For Research Resources2011
- UNC Clinical Translation Science Award-T32 Program (TL1)National Center For Research Resources2010–2011
- UNC Clinical Translation Science Award-K12 Scholars Program (KL2)National Center For Research Resources2010–2011
Professional Memberships
- Member
External Links
- Learn more about Dr. Marschall Rungehttps://www.google.com/url?q=https://marschallrungemd.com&source=gmail&ust=1782580250658000&sa=E
- LinkedInhttps://www.linkedin.com/in/marschallsrunge/
- University of Michigan Profilehttps://medschool.umich.edu/profile/3101/marschall-runge
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
